Andreas Weigert
Impact in
- Immunology top 0.5%
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Psoriasis: Treatment and Pathogenesis
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Immunology 108
- Immune cells in cancer 59
- Phagocytosis and Immune Regulation 14
- T-cell and B-cell Immunology 10
- Psoriasis: Treatment and Pathogenesis 7
- Oncology 37
- Cancer Immunotherapy and Biomarkers 18
- Cancer Cells and Metastasis 9
- Co-authors
- Bernhard Brüne (121 shared papers)Andreas von Knethen (23 shared papers)Javier Mora (17 shared papers)Nathalie Dehne (12 shared papers)Gerd Geißlinger (27 shared papers)Rajkumar Savai (29 shared papers)Dmitry Namgaladze (8 shared papers)Michaela Jung (13 shared papers)
- Journals
- Frontiers in Immunology (18 papers)International Journal of Molecular Sciences (14 papers)Blood (5 papers)Cells (5 papers)Redox Biology (4 papers)
- Partner nations
- GermanyUnited StatesCosta Rica
In The Last Decade
Andreas Weigert
231 papers receiving 9.2k citations
Andreas Weigert's Hit Papers
Peers
Comparison fields: 5 of 127
- Immunology 2.6k
- Oncology 1.6k
- Cancer Research 629
- Molecular Biology 2.8k
- Biochemistry 159
Countries citing papers authored by Andreas Weigert
This map shows the geographic impact of Andreas Weigert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Weigert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Weigert more than expected).
Fields of papers citing papers by Andreas Weigert
This network shows the impact of papers produced by Andreas Weigert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Weigert. The network helps show where Andreas Weigert may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Weigert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 241 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 327 | |
| 2 | Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer Hit paper breakdown → | 2022 | 269 |
| 3 | 2017 | 240 | |
| 4 | 2017 | 239 | |
| 5 | 2017 | 224 | |
| 6 | 2014 | 219 | |
| 7 | 2020 | 180 | |
| 8 | 2020 | 156 | |
| 9 | 2006 | 153 | |
| 10 | 2007 | 153 | |
| 11 | 2016 | 152 | |
| 12 | 2009 | 147 | |
| 13 | 2010 | 146 | |
| 14 | 2017 | 144 | |
| 15 | 2020 | 134 | |
| 16 | 2019 | 129 | |
| 17 | 2008 | 128 | |
| 18 | 2019 | 104 | |
| 19 | 2015 | 103 | |
| 20 | 2009 | 94 |
About Andreas Weigert
Andreas Weigert is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Pharmacology, having authored 241 papers that have together received 9.3k indexed citations. Recurring topics across this work include Immune cells in cancer (59 papers), Sphingolipid Metabolism and Signaling (30 papers), Cancer Immunotherapy and Biomarkers (18 papers), Phagocytosis and Immune Regulation (14 papers), Inflammatory mediators and NSAID effects (11 papers), T-cell and B-cell Immunology (10 papers), Cancer Cells and Metastasis (9 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). The work is most often cited by research in Immunology (2.6k citations), Oncology (1.6k citations), Cancer Research (629 citations), Molecular Biology (2.8k citations) and Biochemistry (159 citations). Andreas Weigert has collaborated with scholars based in Germany, United States and Costa Rica. Frequent co-authors include Bernhard Brüne, Andreas von Knethen, Javier Mora, Nathalie Dehne, Gerd Geißlinger, Rajkumar Savai, Dmitry Namgaladze, Michaela Jung, Werner Seeger and Tobias Schmid. Their work appears in journals such as Frontiers in Immunology, International Journal of Molecular Sciences, Blood, Cells and Redox Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.